Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders
暂无分享,去创建一个
[1] G. Dawson,et al. The screening and diagnosis of autistic spectrum disorders. , 2004, Journal of autism and developmental disorders.
[2] J. R. Reigart,et al. The Effect of Chelation Therapy With Succimer on Neuropsychological Development in Children Exposed to Lead , 2003 .
[3] B. Goldstein,et al. The precautionary principle also applies to public health actions. , 2001, American journal of public health.
[4] D. Kriebel,et al. Reenergizing public health through precaution. , 2001, American journal of public health.
[5] L. Goldman,et al. Balancing risks and benefits: Primum non nocere is too simplistic. , 2001, Pediatrics.
[6] S. Folstein,et al. Evidence supporting WNT2 as an autism susceptibility gene. , 2001, American journal of medical genetics.
[7] L. Goldman,et al. Technical report: mercury in the environment: implications for pediatricians. , 2001, Pediatrics.
[8] L. Mell,et al. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. , 2001, Pediatrics.
[9] E. Fombonne,et al. Pervasive developmental disorders in preschool children. , 2001, JAMA.
[10] Robert L. Jones,et al. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. , 2001, The New England journal of medicine.
[11] L. Ball,et al. An assessment of thimerosal use in childhood vaccines. , 2001, Pediatrics.
[12] J. Seal,et al. What happened to primum non nocere? , 2001, Pediatrics.
[13] D. Lauderdale,et al. Impact of recommendations to suspend the birth dose of hepatitis B virus vaccine. , 2001, JAMA.
[14] S Bernard,et al. Autism: a novel form of mercury poisoning. , 2001, Medical hypotheses.
[15] J. P. Davis,et al. Impact of the Joint Statement by the American Academy of Pediatrics/US Public Health Service on Thimerosal in Vaccines on Hospital Infant Hepatitis B Vaccination Practices , 2001, Pediatrics.
[16] L. Dales,et al. Time trends in autism and in MMR immunization coverage in California. , 2001, Journal of the American Medical Association (JAMA).
[17] H. Feldman,et al. Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. , 2001, Pediatrics.
[18] T. Wassink,et al. Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder , 2001, Molecular Psychiatry.
[19] H Jick,et al. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis , 2001, BMJ : British Medical Journal.
[20] E. Fombonne. Is there an epidemic of autism? , 2001, Pediatrics.
[21] W. Barbaresi,et al. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. , 2001, JAMA.
[22] G. Wilson. The Hazards of Immunization , 2000 .
[23] H. Peltola,et al. Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. , 2000, The Pediatric infectious disease journal.
[24] P. Rodier,et al. Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders. , 2000, Teratology.
[25] E. Maibach,et al. Do Parents Understand Immunizations? A National Telephone Survey , 2000, Pediatrics.
[26] P. Tanguay. Pervasive developmental disorders: a 10-year review. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.
[27] G. Wilding,et al. Neurodevelopmental outcomes of Seychellois children from the pilot cohort at 108 months following prenatal exposure to methylmercury from a maternal fish diet. , 2000, Environmental research.
[28] P. Turnpenny,et al. A clinical study of 57 children with fetal anticonvulsant syndromes , 2000, Journal of medical genetics.
[29] W. Sexson,et al. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants. , 2000, The Journal of pediatrics.
[30] J. Law,et al. Prevalence and natural history of primary speech and language delay: findings from a systematic review of the literature. , 2000, International journal of language & communication disorders.
[31] G. Ginsberg,et al. Development of a Single‐Meal Fish Consumption Advisory for Methyl Mercury , 2000, Risk analysis : an official publication of the Society for Risk Analysis.
[32] J B Tomblin,et al. Prevalence of speech delay in 6-year-old children and comorbidity with language impairment. , 1999, Journal of speech, language, and hearing research : JSLHR.
[33] N. Halsey,et al. Limiting infant exposure to thimerosal in vaccines and other sources of mercury. , 1999, JAMA.
[34] G. Evans,et al. Vaccine injury compensation programs worldwide. , 1999, Vaccine.
[35] Mark D. Miller,et al. Thimerosal in Vaccines—An Interim Report to Clinicians , 1999, Pediatrics.
[36] M. Salive,et al. An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group. , 1999, Vaccine.
[37] E. Fombonne,et al. The epidemiology of autism: a review , 1999, Psychological Medicine.
[38] Jun Li,et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association , 1999, The Lancet.
[39] A K Leung,et al. Evaluation and management of the child with speech delay. , 1999, American family physician.
[40] C. Gillberg,et al. Autism: not an extremely rare disorder , 1999, Acta psychiatrica Scandinavica.
[41] J A Cipkala-Gaffin,et al. Diagnosis and treatment of attention-deficit/hyperactivity disorder. , 1998, Perspectives in psychiatric care.
[42] C Cox,et al. Effects of prenatal and postnatal methylmercury exposure from fish consumption on neurodevelopment: outcomes at 66 months of age in the Seychelles Child Development Study. , 1998, JAMA.
[43] A. Sabrá,et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children , 1998, The Lancet.
[44] P. Leinikki,et al. No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study , 1998, The Lancet.
[45] D. Weed,et al. Biologic plausibility in causal inference: current method and practice. , 1998, American journal of epidemiology.
[46] Roberta F. White,et al. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. , 1997, Neurotoxicology and teratology.
[47] T. Howard,et al. Mercury poisoning associated with high-dose hepatitis-B immune globulin administration after liver transplantation for chronic hepatitis B. , 1996, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[48] R. Schoeny,et al. Mercury study report to Congress. Volume 1. Executive summary. Sab review draft , 1996 .
[49] M. Wolraich,et al. FURTHER EXAMINATION OF DIAGNOSTIC CRITERIA FOR ATTENTION DEFICIT/HYPERACTIVITY DISORDER (DSM-IV) IN A COUNTY-WIDE SAMPLE. †110 , 1996, Pediatric Research.
[50] H. Kraemer,et al. State of the science in autism: Report to the National institutes of health , 1996, Journal of autism and developmental disorders.
[51] M. Wolraich,et al. Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.
[52] P. Griem,et al. Metal ion induced autoimmunity. , 1995, Current opinion in immunology.
[53] R. Eme,et al. Sex differences in conduct disorder , 1995 .
[54] D. Carpenter,et al. Communicating with the public on issues of science and public health. , 1995, Environmental health perspectives.
[55] J. Piven,et al. Diagnosis, treatment, and neurobiology of autism in children. , 1995, Current opinion in pediatrics.
[56] S Eneström,et al. Does amalgam affect the immune system? A controversial issue. , 1995, International archives of allergy and immunology.
[57] G. Whitehurst,et al. Practitioner review: early developmental language delay: what, if anything, should the clinician do about it? , 1994, Journal of child psychology and psychiatry, and allied disciplines.
[58] C. Gillberg,et al. AUTISM IN THALIDOMIDE EMBRYOPATHY: A POPULATION STUDY , 1994, Developmental medicine and child neurology.
[59] E. Söderman,et al. DMSA Administration to Patients with Alleged Mercury Poisoning from Dental Amalgams: A Placebo-controlled Study , 1994, Journal of dental research.
[60] P. Decouflé,et al. Prevalence and health impact of developmental disabilities in US children. , 1994, Pediatrics.
[61] N. Ballatori,et al. Methylmercury transport across the blood-brain barrier by an amino acid carrier. , 1992, The American journal of physiology.
[62] H. Satoh,et al. Exposure to mercury via breast milk in suckling offspring of maternal guinea pigs exposed to mercury vapor after parturition. , 1992, Journal of toxicology and environmental health.
[63] M. Aschner,et al. Mercury neurotoxicity: Mechanisms of blood-brain barrier transport , 1990, Neuroscience & Biobehavioral Reviews.
[64] C. Stegbauer. Guide to Clinical Preventive Services , 1990, Journal of the American Osteopathic Association.
[65] N. Cox,et al. Thiomersal allergy and vaccination reactions , 1988, Contact dermatitis.
[66] C. Cox,et al. Fetal methylmercury poisoning. Relationship between concentration in single strands of maternal hair and child effects. , 1987, Archives of neurology.
[67] N. Ballatori,et al. Dependence of biliary secretion of inorganic mercury on the biliary transport of glutathione. , 1984, Biochemical pharmacology.
[68] G. A. Wood,et al. Mercury toxicity following merthiolate ear irrigations. , 1984, The Journal of pediatrics.
[69] P. Silva,et al. DEVELOPMENTAL LANGUAGE DELAY FROM THREE TO SEVEN YEARS AND ITS SIGNIFICANCE FOR LOW INTELLIGENCE AND READING DIFFICULTIES AT AGE SEVEN , 1983, Developmental medicine and child neurology.
[70] E. Gelfand,et al. Mercury toxicity (acrodynia) induced by long-term injection of gammaglobulin. , 1980, The Journal of pediatrics.
[71] I. Cincă,et al. Accidental ethyl mercury poisoning with nervous system, skeletal muscle, and myocardium injury. , 1980, Journal of neurology, neurosurgery, and psychiatry.
[72] T. Clarkson,et al. Organ mercury levels in infants with omphaloceles treated with organic mercurial antiseptic. , 1977, Archives of disease in childhood.
[73] T. Clarkson,et al. Perinatal methylmercury poisoning in Iraq. , 1976, American journal of diseases of children.
[74] H. Maibach,et al. Acute laryngeal obstruction presumed secondary to thiomersal (merthiolate) delayed hypersensitivity , 1975, Contact dermatitis.
[75] T W Clarkson,et al. Methylmercury poisoning in Iraq. , 1973, Science.
[76] J. Axton. Six cases of poisoning after a parenteral organic mercurial compound (Merthiolate) , 1972, Postgraduate medical journal.
[77] T. Terao,et al. Mercury compounds in the blood of rats treated with ethylmercuric chloride. , 1968, Toxicology and applied pharmacology.
[78] Q. Hill. Appendix A , 1967, Intratextual Baudelaire.
[79] T. Suzuki,et al. COMPARATIVE STUDY OF BODILY DISTRIBUTION OF MERCURY IN MICE AFTER SUBCUTANEOUS ADMINISTRATION OF METHYL, ETHYL AND N-PROPYL MERCURY ACETATES. , 1963, The Japanese journal of experimental medicine.
[80] J. Cumings,et al. Organic mercurial encephalopathy , 1963, Journal of neurology, neurosurgery, and psychiatry.
[81] M. Jalili,et al. Poisoning by Ethyl Mercury Toluene Sulphonanilide , 1961, British journal of industrial medicine.
[82] C. Dolea,et al. World Health Organization , 1949, International Organization.
[83] H. M. Powell,et al. Merthiolate As a Preservative for Biological Products , 1931, The Journal of Immunology.
[84] L. Magos. Review on the toxicity of ethylmercury, including its presence as a preservative in biological and pharmaceutical products , 2001, Journal of applied toxicology : JAT.
[85] Impact of the 1999 AAP/USPHS joint statement on thimerosal in vaccines on infant hepatitis B vaccination practices. , 2001, MMWR. Morbidity and mortality weekly report.
[86] Rita Schoeny,et al. Water Quality Criterion for the Protection of Human Health: Methylmercury , 2001 .
[87] Thiomersal as a vaccine preservative. , 2000, Releve epidemiologique hebdomadaire.
[88] Dallas,et al. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2000, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[89] Update: expanded availability of thimerosal preservative-free hepatitis B vaccine. , 2000, MMWR. Morbidity and mortality weekly report.
[90] Summary of the joint statement on thimerosal in vaccines. American Academy of Family Physicians, American Academy of Pediatrics, Advisory Committee on Immunization Practices, Public Health Service. , 2000, MMWR. Morbidity and mortality weekly report.
[91] P. Offit,et al. Preventing harm from thimerosal in vaccines. , 2000, JAMA.
[92] Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. , 1999, The Annals of pharmacotherapy.
[93] Availability of hepatitis B vaccine that does not contain thimerosal as a preservative. , 1999, MMWR. Morbidity and mortality weekly report.
[94] K. Mahaffey. Methylmercury: a new look at the risks. , 1999, Public health reports.
[95] N. Cox. Prevention and control of influenza. , 1999, Lancet.
[96] K. Pollard,et al. Effects of mercury on the immune system. , 1997, Metal ions in biological systems.
[97] S. M. Hewitt,et al. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP) , 1997, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[98] Michigan.,et al. Toxicological profile for dichloropropenes , 2008 .
[99] S S Ellenberg,et al. The complicated task of monitoring vaccine safety. , 1997, Public health reports.
[100] T. Zilker,et al. Clinical course of severe poisoning with thiomersal. , 1996, Journal of toxicology. Clinical toxicology.
[101] R. Johnston,et al. Options for Poliomyelitis Vaccination in the United States , 1996 .
[102] M. Harada,et al. Minamata disease: methylmercury poisoning in Japan caused by environmental pollution. , 1995, Critical reviews in toxicology.
[103] P. Davidson,et al. The biological monitoring of mercury in the Seychelles study. , 1995, Neurotoxicology.
[104] C Cox,et al. Longitudinal neurodevelopmental study of Seychellois children following in utero exposure to methylmercury from maternal fish ingestion: outcomes at 19 and 29 months. , 1995, Neurotoxicology.
[105] D. Nalin. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality , 1994, The Yale Journal of Biology and Medicine.
[106] R. Johnston,et al. DPT Vaccine and Chronic Nervous System Dysfunction: A New Analysis , 1994 .
[107] A. Oskarsson,et al. Placental and lactational transfer of mercury from rats exposed to methylmercury in their diet : speciation of mercury in the offspring , 1992 .
[108] S. Nightingale. Seafood safety. , 1990, American family physician.
[109] P. Wade,et al. Prenatal and neonatal toxicology and pathology of heavy metals. , 1980, Advances in pharmacology and chemotherapy.
[110] T. Clarkson. The pharmacology of mercury compounds. , 1972, Annual review of pharmacology.
[111] H. Tokuomi,et al. [Minamata disease]. , 1968, Naika. Internal medicine.
[112] S. Damluji. Mercurial Poisoning with the Fungicide Granosan M. , 1962 .
[113] H. M. Powell,et al. MERTHIOLATE AS A GERMICIDE , 1931 .